Oral Antidiabetic Drugs Market Size Worth USD 57 Billion Globally By 2029, Size, Share, Rising Trends And Market Demand

Published October 23, 2023

Data Bridge Market Research recently conducted a comprehensive market intelligence study, conducting an in-depth analysis of the Oral Antidiabetic Drugs Market. The newly published report employs an attractive format, presenting essential data through visually engaging tables, graphs, charts, and figures.

This Oral Antidiabetic Drugs report provides information about historical data, current market trends, future product developments, marketing strategies, technological innovations, upcoming technologies, emerging trends, and opportunities. The report also assesses the market potential for each geographical region, considering growth rates, macroeconomic factors, consumer purchasing patterns, product preferences, and market supply and demand scenarios. The Oral Antidiabetic Drugs report explores the growing opportunities in the market and the associated influencing factors, which are valuable for businesses. It serves as an indispensable document for market enthusiasts, policymakers, investors, and industry participants.

To thrive in this rapidly evolving marketplace, businesses must adopt this solution provided by the Oral Antidiabetic Drugs market research report. This market report examines the market with regard to general market conditions, market advancements, market scenarios, development prospects, costs and profits in specific market regions, as well as the positioning and comparative pricing of major players. The data and information included in this Oral Antidiabetic Drugs report not only assist businesses in making data-driven decisions but also ensure the maximization of return on investment (ROI). The report is the result of a series of steps involving input from a dedicated team of researchers, analysts, and forecasters.

Data Bridge Market Research analyses a growth rate in the global oral antidiabetic drugs market in the forecast period 2022-2029. The expected CAGR of global oral antidiabetic drugs market is tend to be around 3% in the mentioned forecast period. The market was valued at USD 45 billion in 2021, and it would grow upto USD 57 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oral-antidiabetic-drugs-market&AM

 The global oral antidiabetic drugs market is expected to witness significant growth during the forecast period. Increasing cases of type 2 diabetes boosts the oral antidiabetic drugs market. The adaptation of unhealthy lifestyle, environment pollution and family history with diabetes disease also boost up the oral antidiabetic drugs market growth. Many major market players are contributing a lot in drug discovery and development. COVID-19 also had a major impact on the market growth.

Key Growth Drivers:

  • Rising Incidence of Diabetes

The adult diabetes population in 2021 was approximately 537 million, and this number is going to rise high to 643 million in 2030. There are several factors such as obesity, unhealthy diet, and physical inactivity because of which the rate of newly diagnosed cases of Type 1 and Type 2 diabetes is seen to increase. Thus, this boosts the market growth.

The report outlines the involvement of key players, including:

Pfizer Inc (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (U.S.), Fresenius Kabi AG (Germany), Hikma Pharmaceuticals PLC (U.K.), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Bristol Myers Squibb Company (U.S.) GSK Plc. (U.S.), Bayer AG

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-oral-antidiabetic-drugs-market?AM

 Key Market Segmentation

Drug Class (Biguanides, Thiazolidinediones, Dipeptidyl Peptidase IV Inhibitors, α-Glucosidase Inhibitors, Insulin Secretagogues, Amylin Analog,  Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

The Oral Antidiabetic Drugs market report includes the following countries in different regions:

The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here’s an overview of the regions and the countries they include:

  1. North America: United States, Canada, and Mexico.
  2. Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
  3. Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
  4. Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
  5. South America: Brazil, Argentina, and other countries in South America.


Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Get the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-oral-antidiabetic-drugs-market&AM

Browse More Reports:







About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – 

CDN Newswire